Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Pulse BiosciencesPulse Biosciences(US:PLSE) Businesswire·2025-12-30 05:05

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the intention as well as potential to improve the quality of life for patients. The Company's proprietary nPulse™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its nPulse technology for use in the treatment of atrial fibrillation and in a select few other markets where it coul ...